Педиатрическая фармакология (Feb 2010)
RECOMMENDATIONS FOR DIAGNOSTICS AND TREATMENT OF NIEMANN-PICK TYPE C DISEASE
- James E. Wraith,
- Matthias R. Baumgartner,
- Bruno Bembi,
- Athanasios Covanis,
- Thierry Levade,
- Eugen Mengel,
- Merce Pineda,
- Frederic Sedel,
- Meral Topcu,
- Marie T. Vanier,
- Hakan Widner,
- Frits A. Wijburg,
- Marc C. Pattersonm
Affiliations
- James E. Wraith
- Willink Biochemical Genetics Unit, Royal Manchester Children’s Hospital, Manchester M27 4HA
- Matthias R. Baumgartner
- Division of Metabolism, University Children’s Hospital, Steinwiessstrasse 75, Zurich 8032
- Bruno Bembi
- Regional Coordinator Centre for rare diseases, Azienda Ospedaliera S. Maria della Misericordia, Udine
- Athanasios Covanis
- Children’s Hospital Agia Sophia, Athens
- Thierry Levade
- INSERM Unit 858, Toulouse 31432
- Eugen Mengel
- Villa Metabolica, University of Mainz, Mainz
- Merce Pineda
- Centre for Biomedical Research on Rare Diseases (CIBERER), Hospital Sant Joan de De\u, Passeig de Sant Jaon de De\u n_ 2, Barcelona 8950
- Frederic Sedel
- Hopital Pitie\ Salpetriere, 47, Boulevard de l’hopital, Paris 75651, Cedex 13
- Meral Topcu
- Department of Child Neurology, Hacettepe University Children’s Hospital, Ankara 6100
- Marie T. Vanier
- INSERM Unit 820, 7 rue G. Paradin, Laennec Medical School, Lyon 69372, Cedex 08
- Hakan Widner
- Department of Neurology, Lund University Hospital, Lund
- Frits A. Wijburg
- Academic Medical Center, Meibergdreef 15, Amsterdam 1100 DD
- Marc C. Pattersonm
- Department of Neurology Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 16 – 24
Abstract
(Pediatric Pharmacology. – 2010; 7(1):16-24)
